Eastern Commercial Leasing PCL
SET:ECL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eastern Commercial Leasing PCL
SET:ECL
|
TH |
|
G
|
Genufood Energy Enzymes Corp
OTC:GFOO
|
US |
|
Vaccitech PLC
F:2AB
|
UK |
|
A
|
Asia Pacific Investment JSC
VN:API
|
VN |
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
KR |
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
TH |
|
Vinci SA
PAR:DG
|
FR |
|
B
|
Biotoxtech Co Ltd
KOSDAQ:086040
|
KR |
|
A
|
Akola Group AB
XMUN:YG4
|
LT |
|
C
|
Clariant AG
SIX:CLN
|
CH |
|
Interpump Group SpA
MIL:IP
|
IT |
|
Nitto Fuji Flour Milling Co Ltd
TSE:2003
|
JP |
|
Schibsted ASA
F:XPG
|
NO |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ECL's stock price target?
Not Available
ECL doesn't have any price targets made by Wall Street professionals.
What is Eastern Commercial Leasing PCL's Revenue forecast?
Projected CAGR
3%
For the last 8 years the compound annual growth rate for Eastern Commercial Leasing PCL's revenue is 12%. The projected CAGR for the next 1 year is 3%.
What is Eastern Commercial Leasing PCL's Operating Income forecast?
Projected CAGR
37%
For the last 8 years the compound annual growth rate for Eastern Commercial Leasing PCL's operating income is 9%. The projected CAGR for the next 1 year is 37%.
What is Eastern Commercial Leasing PCL's Net Income forecast?
Projected CAGR
203%
For the last 8 years the compound annual growth rate for Eastern Commercial Leasing PCL's net income is 10%. The projected CAGR for the next 1 year is 203%.
